1 |
5-[4-[2-(5-(1-hydroxyethyl)-2- pyridinyl)ethoxy]benzyl]-2,4- thiazolidinedione hydrochloride |
2,4-thiazolidinedione |
- |
- |
- |
020 1件: 20 💬 |
2 |
5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride |
2,4-thiazolidinedione |
- |
- |
- |
020 1件: 20 💬 |
3 |
5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione hydrochloride |
2,4-thiazolidinedione |
- |
- |
- |
020 1件: 20 💬 |
4 |
Acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 16件: 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
5 |
Albumin |
- |
- |
- |
- |
002 3件: 2 , 20, 51 💬 |
6 |
Albumin solution |
- |
- |
- |
- |
020 1件: 20 💬 |
7 |
Albunorm® 5%, |
- |
- |
- |
- |
020 1件: 20 💬 |
8 |
Alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
9 |
Autologous cd34+ cells transduced with lenti-d vector encoding abcd1 cdna |
- |
- |
- |
- |
020 1件: 20 💬 |
10 |
Autologous haematopoietic stem cells transduced with lentiviral vector lenti-d encoding the human abcd1 cdna |
- |
- |
- |
- |
020 1件: 20 💬 |
11 |
Bezafibrate |
Bezafibrate |
1件: D01366 D01366 💬 |
PPARA 1件: PPARA 💬 |
Adipocytokine signaling pathway 8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway |
020 6件: 20, 93, 94, 160, 316, 324 💬 |
12 |
Biotin |
Biotin |
1件: D00029 D00029 💬 |
- |
- |
002 5件: 2 , 8 , 10, 13, 20 💬 |
13 |
Busulfan |
Busulfan |
1件: D00248 D00248 💬 |
- |
- |
019 13件: 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬 |
14 |
Busulfan, cyclophosphamide, antithymocyte globulin |
Busulfan |
3件: D00248 D00248, D00287 D00287, D07760 D07760 💬 |
- |
- |
019 2件: 19, 20 💬 |
15 |
Cald hr-d (high-risk, regimen c) |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
16 |
Cald hr-d (high-risk, regimen d) |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
17 |
Cald sr-a (standard-risk, regimen a) |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
18 |
Cald sr-b (standard-risk, regimen b) |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
19 |
Campath |
- |
- |
- |
- |
019 12件: 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬 |
20 |
Campath-1h |
- |
- |
- |
- |
019 6件: 19, 20, 60, 234, 285, 326 💬 |
21 |
Chenodeoxycholic acid |
Chenodeoxycholic acid |
1件: D00163 D00163 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
020 4件: 20, 96, 234, 263 💬 |
22 |
Cholic acid |
Cholic Acid |
1件: D10699 D10699 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
020 4件: 20, 234, 265, 310 💬 |
23 |
Cholic acids |
- |
- |
- |
- |
020 2件: 20, 234 💬 |
24 |
Clofarabine |
Clofarabine |
1件: D03546 D03546 💬 |
POLA1 3件: POLA1, POLA2, RRM1 💬 |
DNA replication 6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
019 9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 💬 |
25 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
26 |
Cyclosporine |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 35件: 11, 19, 20, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 62, 63, 64, 65, 90, 95, 97, 162, 164, 222, 226, 228, 234, 283, 284, 285, 302 💬 |
27 |
Cyclosporine a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 10件: 19, 20, 36, 49, 50, 53, 58, 60, 234, 283 💬 |
28 |
D-biotin |
Biotin |
1件: D00029 D00029 💬 |
- |
- |
010 3件: 10, 13, 20 💬 |
29 |
Device: cyclosporine a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 2件: 19, 20 💬 |
30 |
Duoc-01 |
- |
- |
- |
- |
019 2件: 19, 20 💬 |
31 |
Elivaldogene autotemcel |
- |
- |
- |
- |
020 1件: 20 💬 |
32 |
Elivaldogenum tavalentivecum |
- |
- |
- |
- |
020 1件: 20 💬 |
33 |
Glyceryl trierucate |
Glyceryl Trierucate |
- |
- |
- |
020 1件: 20 💬 |
34 |
Glyceryl trierucate/glyceryl trioleate |
Glyceryl Trierucate |
- |
- |
- |
020 1件: 20 💬 |
35 |
Glyceryl trioleate |
Glyceryl Trioleate |
- |
- |
- |
020 1件: 20 💬 |
36 |
Hematopoietic stem cell infusion |
- |
- |
- |
- |
019 2件: 19, 20 💬 |
37 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 12件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
38 |
Human placental derived stem cell |
- |
- |
- |
- |
019 4件: 19, 20, 60, 284 💬 |
39 |
Hydroxyurea |
Hydroxyurea |
1件: D00341 D00341 💬 |
RRM2 1件: RRM2 💬 |
Drug metabolism - other enzymes 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway |
003 8件: 3 , 13, 19, 20, 65, 85, 86, 284 💬 |
40 |
Imd |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
41 |
Imd preparative regimen |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
42 |
Interferon beta |
Human interferon beta |
- |
- |
- |
013 5件: 13, 20, 26, 96, 97 💬 |
43 |
Lenti-d |
- |
- |
- |
- |
020 1件: 20 💬 |
44 |
Lenti-d drug product |
- |
- |
- |
- |
020 1件: 20 💬 |
45 |
Leriglitazone |
Leriglitazone |
1件: D11603 D11603 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
020 1件: 20 💬 |
46 |
Lipoic acid |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
002 5件: 2 , 5 , 13, 14, 20 💬 |
47 |
Lorenzo's oil |
- |
- |
- |
- |
020 1件: 20 💬 |
48 |
Md1003 |
- |
- |
- |
- |
002 5件: 2 , 10, 13, 14, 20 💬 |
49 |
Md1003 100 mg capsule |
- |
- |
- |
- |
020 1件: 20 💬 |
50 |
Melphalan |
Melphalan |
1件: D00369 D00369 💬 |
- |
- |
011 15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
51 |
Mesenchymal stem cells |
- |
- |
- |
- |
002 11件: 2 , 6 , 13, 20, 49, 51, 60, 96, 222, 274, 299 💬 |
52 |
Min-102 |
- |
- |
- |
- |
018 2件: 18, 20 💬 |
53 |
Modified cobratoxin |
- |
- |
- |
- |
020 1件: 20 💬 |
54 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
55 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
56 |
Mycophenylate mofetil |
- |
- |
- |
- |
019 2件: 19, 20 💬 |
57 |
N-acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 10件: 6 , 13, 19, 20, 49, 58, 85, 111, 164, 299 💬 |
58 |
Nv1205 |
- |
- |
- |
- |
020 1件: 20 💬 |
59 |
Osteopetrosis haploidentical only preparative regimen |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
60 |
Osteopetrosis only preparative regimen |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
61 |
Pioglitazone |
Pioglitazone |
2件: D00945 D00945, D08378 D08378 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
62 |
Plerixafor |
Plerixafor |
1件: D08971 D08971 💬 |
CXCR4 1件: CXCR4 💬 |
Axon guidance 12件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor |
020 5件: 20, 51, 65, 285, 299 💬 |
63 |
Procedure: allogeneic stem cell transplantation |
- |
- |
- |
- |
019 3件: 19, 20, 62 💬 |
64 |
Procedure: stem cell transplant |
- |
- |
- |
- |
019 5件: 19, 20, 65, 164, 284 💬 |
65 |
Procedure: total body irradiation |
- |
- |
- |
- |
019 6件: 19, 20, 51, 60, 65, 285 💬 |
66 |
Qtxew2-04-af, ew2, gc-1, qrx-431 |
- |
- |
- |
- |
020 1件: 20 💬 |
67 |
Rpi78m for injection |
- |
- |
- |
- |
020 1件: 20 💬 |
68 |
Sobetirome |
Sobetirome |
1件: D09381 D09381 💬 |
THRB 1件: THRB 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
020 1件: 20 💬 |
69 |
Sobetirome (nv1205) |
Sobetirome |
1件: D09381 D09381 💬 |
THRB 1件: THRB 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
020 1件: 20 💬 |
70 |
Stem cell transplantation |
- |
- |
- |
- |
013 10件: 13, 19, 20, 46, 65, 90, 125, 164, 234, 326 💬 |
71 |
Thalidomide |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 20件: 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
72 |
Thiazolidinedione |
2,4-thiazolidinedione |
- |
- |
- |
020 1件: 20 💬 |
73 |
Thiotepa |
Thiotepa |
1件: D00583 D00583 💬 |
- |
- |
013 11件: 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284 💬 |
74 |
Thiotepa--escalated dose |
Thiotepa |
1件: D00583 D00583 💬 |
- |
- |
019 4件: 19, 20, 65, 284 💬 |
75 |
Thiotepa--single daily dose |
Thiotepa |
1件: D00583 D00583 💬 |
- |
- |
019 4件: 19, 20, 65, 284 💬 |
76 |
Ursodiol |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
008 6件: 8 , 20, 93, 97, 234, 299 💬 |
77 |
Vitamin d3 |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 11件: 6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬 |
78 |
Vitamin e |
Vitamin E |
1件: D02331 D02331 💬 |
- |
- |
002 11件: 2 , 6 , 13, 20, 46, 90, 96, 97, 206, 299, 317 💬 |